Pulse Biosciences, Inc. (PLSE) Net income 2016–2025
Pulse Biosciences, Inc. (PLSE) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$72.8MFY2025 · since FY2016: -$9.5M → -$72.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$72.8M | -35.8% |
| FY2024 | -$53.6M | -26.9% |
| FY2023 | -$42.2M | +27.9% |
| FY2022 | -$58.5M | +8.1% |
| FY2021 | -$63.7M | -27.7% |
| FY2020 | -$49.9M | -6.1% |
| FY2019 | -$47.0M | -25.1% |
| FY2018 | -$37.5M | -46.8% |
| FY2017 | -$25.6M | -168.6% |
| FY2016 | -$9.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PLSE financial trends
PLSE RevenuePLSE Net marginPLSE Gross profitPLSE Gross marginPLSE Operating incomePLSE Operating marginPLSE Operating cash flowPLSE Free cash flowPLSE Capital expendituresPLSE Return on equityPLSE Stock buybacksPLSE Dividends paidPLSE Total assetsPLSE Total liabilitiesPLSE Shareholders’ equityPLSE overview →